ABSTRACT A study was conducted to identify the cytochrome P450 (CYP, CYP450) enzyme orthologs involved in the bioactivation of aflatoxin B 1 (AFB 1 ) into the highly toxic metabolite known as aflatoxin-8,9-epoxide (AFBO) in quail and chicken hepatic microsomes. The strategies used included the use of specific CYP450 inhibitors and the correlation of prototype substrate activities with AFBO production. Additionally, the presence of the enzymes was qualitatively determined using an immunoblotting technique. The results showed that both quail and chicken microsomes have CYP1A1, CYP1A2, CYP2A6, and CYP3A4 enzymatic activity. A strong relationship between CYP1A1 and CYP2A6 activities and AFB 1 bioactivation was found in both species. Inhibition studies provided more evidence for the role of CYP2A6 in the bioactivation of AFB 1 . The immunoblot results showed clear bands for the CYP2A6 and CYP3A4 orthologs in both species. The results of the present study indicate that CYP2A6 and, to a lesser extent, CYP1A1 are responsible for the bioactivation of AFB 1 into AFBO in both quail and chicken hepatic microsomes.
INTRODUCTION
Mycotoxins are secondary metabolites produced by toxigenic strains of different species of fungi. Mycotoxins are of toxicological concern because they are able to affect human health and livestock and poultry productivity. Thousands of compounds can be produced by toxigenic fungi and more than 300 secondary metabolites produced mainly by filamentous fungi from the genera Aspergillus, Penicillium, and Fusarium have been classified as mycotoxins (Bünger et al., 2004) .
Aflatoxin B 1 (AFB 1 ) is one of the most important mycotoxins due to its hepatotoxic and carcinogenic effects on certain animal models and humans (McLean and Dutton, 1995; Wild and Turner, 2002; Williams et al., 2004) . Aspergillus flavus and Aspergillus parasiticus are the most important fungi responsible for its production (Sargeant et al., 1961) . Aflatoxin B 1 is bioactivated by cytochrome P450 (CYP, CYP450), a group of enzymes abundant in the liver and related with the bioactivation and metabolism of different kinds of xenobiotics and endogenous compounds (Josephy, 1997) . Cytochrome P450 enzymes are classified into families identified by a number (e.g., 1, 2, 3, and 4), subfamilies identified by a letter (e.g., 2A, 2B, 2D, and 2E), and specific members identified by another number (e.g., CYP2E1 and CYP2A6) (Josephy, 1997; Klaassen, 2001 ).
The CYP450 enzymes bioactivate AFB 1 to an electrophilic, highly reactive and unstable metabolite that is able to react with cellular macromolecules such as DNA (causing genotoxicity) and proteins (causing cytotoxicity) (Doi et al., 2002) . This reactive metabolite, known as aflatoxin-8,9-epoxide (AFBO), binds to guanine residues in nucleic acids, leading to irreversible damage in DNA and causing hepatocarcinoma in humans, primates, and ducks (Eaton and Gallagher, 1994; Verma, 2004; Do and Choi, 2007; Ferguson and Philpott, 2008) .
The AFBO can be detoxified by conjugation with glutathione or may be hydrolyzed by an epoxide hydrolase to AFB 1 -8,9-dihydrodiol (AFB 1 -dhd), which is able to react strongly with proteins and cause cytotoxicity (Eaton and Gallagher, 1994) . In mammals, CYP1A2 and CYP3A4 are the most important enzymes capable of bioactivating AFB 1 into AFBO, but they can also produce aflatoxin M1, aflatoxin Q1, and other metabolites (Gallagher et al., 1996; Guengerich et al., 1996 Guengerich et al., , 1998 . The presence of CYP450 enzymes capable of biotransforming AFB 1 to reactive metabolites associated with poor conjugation to glutathione is considered to be an important factor in the sensitivity to AFB 1 in several animal models (Tulayakul et al., 2005) . Although AFB 1 biotransformation in mammals is relatively well understood, studies in poultry are still needed (Savlík et al., 2007) . Adverse health effects have been reported in turkeys (Quist et al., 2000; Klein et al., 2002; Rauber et al., 2007) , quail (Oliveira et al., 2002) , chickens (Kadian et al., 1988) , and ducks (Barraud et al., 1999) . However, large differences in the response of poultry species to AFB 1 have been noted (Leeson et al., 1995) and the biochemical basis for these differences has not been elucidated. Our group has previously reported differences in the rate of biotransformation of AFB 1 into its epoxide and dihydrodiol forms in commercial poultry species including ducks, chickens, turkeys, and quail (Lozano and Diaz, 2006) ; however, no studies were conducted to determine the specific CYP450 enzymes responsible for AFBO production.
The aim of the present study was to further characterize the role of CYP450 enzymes in AFB 1 bioactivation into its epoxide form in chicken and quail liver and to identify the specific hepatic CYP450 orthologs responsible for its biotransformation. Several strategies were used including the correlation of AFB 1 epoxidation activity with prototype substrate activities, use of specific inhibitors for CYP450 enzymes, and immunoblotting to determine the presence of the CYP450 avian orthologs.
MATERIALS AND METHODS

Reagents
Aflatoxin B 1 , aflatoxin B2 α , Tris, Tween 20, glucose 6-phosphate sodium salt, glucose 6-phosphate dehydrogenase, EDTA, bicinchoninic acid, copper sulfate, sucrose, glycine, NADP sodium salt hydrate, glycerol, BSA, methoxyresorufin, α-naphthoflavone, 8-methoxypsoralen, oleandomycin triacetate, and 7-hydroxycoumarin were purchased from Sigma Chemical Co. (St. Louis, MO). Sodium chloride and magnesium chloride hexahydrate were from Mallinckrodt Baker (Phillipsburg, NJ). Sodium dihydrogen phosphate monohydrate and disodium hydrogen phosphate anhydrous were from Merck (Darmstadt, Germany). Furafylline, nifedipine, oxidized nifedipine, and human CYP1A2, CYP2A6, CYP3A4, and CYP1A1 were purchased from BD Biosciences (San Jose, CA). Debrisoquine sulfate, 4-hydroxydebrisoquine sulfate, coumarin, ethoxyresorufin, and resorufin sodium salt were purchased from MP Biomedicals (Solon, OH). Primary polyclonal antibodies (rabbit anti-human CYP450) against CYP1A1, CYP1A2, CYP2A6, and CYP3A4 were purchased from AbCam (Cambridge, MA). Low molecular range protein standards, immunoblot polyvinylidene fluoride (PVDF) membranes (7 × 8.4 cm), filter paper (7.5 × 10 cm), 30% acrylamide:bisacrylamide solution (29:1), ammonium persulfate, tetramethylethylenediamine, bromophenol blue, Opti-4CN goat anti-rabbit detection kit, and SDS were purchased from BioRad (Hercules, CA). Methanol, acetonitrile, water, and other solvents used in preparing mobile phases were all HPLC-grade.
Liver Samples
All experiments were carried out at 4°C. Twelve healthy 6-wk-old commercial egg-type quail (6 males and 6 females) and 12 healthy 6-wk-old Ross broiler chickens (6 males and 6 females) obtained from local commercial growers were killed and their livers were extracted immediately. The livers were washed with cold PBS buffer (20 mM phosphates, pH 7.4, 100 mM NaCl) and stored at −70°C until processing.
Microsome Extraction
A frozen liver sample was allowed to thaw and 5 g was carefully minced and homogenized with 10 mL of cold PBS buffer (20 mM phosphates, pH 7.4, with 1 mM EDTA and 250 mM sucrose) for 30 s using a tissue homogenizer (IKA Ultra-Turrax, Staufen, Germany). The homogenate was then centrifuged at 10,000 × g for 30 min at 4°C. The supernatant (10 mL approximately) was collected and transferred to ultracentrifuge tubes kept at 4°C and centrifuged for 90 min at 98,000 × g. Supernatants (cytosolic fraction) were collected and saved for further studies and the resulting pellet was resuspended in 3 mL of storage buffer (20 mM phosphate buffer, pH 7.4, 1 mM EDTA, 250 mM sucrose, and 20% glycerol) and aliquoted in microcentrifuge tubes. Aliquots were stored at −70°C until used. An aliquot was used to determine the protein content by the bicinchoninic acid protein quantification method according to Redinbaugh and Turley (1986) .
Microsomal Incubations
Microsomal incubations were carried out in vitro in 1.5-mL microcentrifuge tubes at 39°C. Incubations contained 5 mM glucose 6-phosphate; 0.5 mM NADP + ; 0.5 IU of glucose 6-phosphate dehydrogenase; 2 µL of AFB 1 (16 to 256 µM for enzyme kinetics and 128 µM for inhibition studies) or the different substrates or inhibitors dissolved in dimethyl sulfoxide; 25 or 100 µg of chicken or quail microsomal protein, respectively; and incubation buffer (50 mM phosphate buffer, pH 7.4, 5 mM MgCl, and 0.5 mM EDTA) to a final volume of 250 µL. Organic solvent concentration did not exceed 1% (Busby et al., 1999) . Reactions were stopped after 10 min of incubation with 250 µL of ice-cold acetonitrile (Blanchard, 1981) and were centrifuged at 12,000 × g for 10 min. Depending on the specific detector response of the substrate or product, or both, from the incubation, dilutions of the supernatant were made before injection into the HPLC as described below.
Enzymatic Activity of Selected CYP450 Prototype Substrates
The following prototype enzymatic activities were determined using HPLC: 7-ethoxyresorufin-O-deethylase (EROD) for CYP1A1 and CYP1A2 (CYP1A1/2), 7-methoxyresorufin-O-deethylase (MROD) for CY-P1A2, coumarin 7-hydroxylase for CYP2A6, debrisoquinone 4-hydroxylase for CYP2D6, and nifedipine oxidation for CYP3A4. The amount of product formed by each enzymatic activity was quantified by HPLC using a Shimadzu Prominence System (Shimadzu Scientific Instruments, Columbia, MD) equipped with a DGU-20A 3 degasser, an LC-20AB pump, a SIL-20A HT autosampler, a CTO-20A column oven, a SPD-20AV UV-vis detector, a RF-10A XL fluorescence detector, and a CBM-20A bus module, all controlled by LC Solutions software. All separations were carried out with an Alltech Alltima HP C18 5-µm column, 150 × 3.0 mm (Alltech Associates Inc., Deerfield, IL).
Chromatographic Conditions
Determination of 7-ethoxyresorufin and its product resorufin (EROD activity) was carried out at room temperature, at a flow rate of 0.3 mL/min using an isocratic mobile phase consisting of 30% phosphate buffer (20 mM phosphate, pH 7.4) and 70% methanol. The analytes were monitored using fluorescence detection at excitation and emission wavelengths of 530 and 580 nm, respectively (Leclercq et al., 1996; Mdegela et al., 2006) . The incubation supernatant was diluted 1:10 with water and 5 µL of the dilute sample was injected into the chromatograph. The same conditions were used for the determination of 7-methoxyresorufin and its product resorufin (MROD activity), except that only 2 µL of the dilute sample was injected into the chromatograph.
Determination of coumarin and its hydroxylated metabolite 7-hydroxycoumarin (CYP2A6 activity) was carried out at room temperature, at a flow rate of 0.4 mL/min, using an isocratic mobile phase consisting of 30% acetonitrile and 70% water. The 2 compounds were monitored using fluorescence detection at excitation and emission wavelengths of 325 and 452 nm, respectively (Fink and Koehler, 1970) . Supernatants were diluted 1:100 with water and 5 µL of the dilute sample was injected into the chromatograph.
Debrisoquine and 4-hydroxydebrisoquine were determined at room temperature, at a flow rate of 0.3 mL/ min, using an isocratic mobile phase consisting of 30% methanol, 70% water, and 0.1% formic acid. Analytes were monitored by fluorescence detection at excitation and emission wavelengths of 210 and 290 nm, respectively (Pereira et al., 2000; Granvil et al., 2002) , and 5 µL of supernatants was analyzed by HPLC without further dilution.
Determination of nifedipine and its metabolite oxidized nifedipine (CYP3A4 activity) was carried out at room temperature, at a flow rate of 0.5 mL/min, using an isocratic mobile phase consisting of 32% acetonitrile and 68% water. The analytes were monitored by UV detection at 270 nm (Shim et al., 1988) and 10 µL of the supernatant was injected directly into the chromatograph without further dilution.
Determination of AFB 1 -dhd and AFB 1 was carried out at 40°C, at a flow rate of 0.35 mL/min. The AFBO production was monitored as the AFB 1 -dhd adduct, which was quantitated using aflatoxin B 2α as standard (given the similar spectral properties of AFB 1 -dhd and aflatoxin B 2α ), as described by Lozano and Diaz (2006) . The compounds were separated using a linear gradient of A: water-0.1% formic acid and B: methanol-0.1% formic acid as follows: 0 min: 30% B, 2 min: 30% B, 7 min: 55% B; and 7.01 min: 30% B. The 2 analytes were monitored by fluorescence detection at excitation and emission wavelengths of 365 and 425 nm, respectively (Majerus and Zakaria, 1992; Gallagher et al., 1996; Lozano and Diaz, 2006) . A 1:100 dilution was made from which 2 µL was injected into the chromatograph.
Determination of Enzyme Kinetic Constants
To estimate the Michaelis-Menten constant (K M ) and maximal velocity (V max ) of the selected CYP450 orthologs, AFB 1 and 4 of the 5 prototype substrates were selected. Debrisoquine 4-hydroxylase activity was excluded from these experiments because no activity was detected in the samples analyzed. Each prototype substrate was tested in 3 randomly selected microsome samples from both male and female quail in duplicate. For EROD activity (CYP1A1/2), concentrations ranging from 4.8 to 0.3 µM 7-ethoxyresorufin were used; for MROD activity (CYP1A2), concentrations from 5.88 to 0.36 µM 7-methoxyresorufin were used; for coumarin 7-hydroxylase activity (CYP2A6), concentrations from 80 to 5 µM coumarin were used; and for nifedipine oxidation (CYP3A4), concentrations from 71.0 to 4.4 µM nifedipine were used. To investigate AFB 1 epoxidation activity, concentrations from 256 to 16 µM AFB 1 were used.
Inhibitors
To further investigate the role of specific CYP450 avian orthologs on the activation of AFB 1 , 4 different inhibitors were used: α-naphthoflavone (for CY-P1A1/2) in a range from 22.95 to 1.43 µM, furafylline (for CYP1A2) from 384.2 to 24 µM, 8-methoxypsoralen (for CYP2A6) from 92.5 to 2.8 µM, and troleandomycin (for CYP3A4) from 122.8 to 7.6 µM. Each inhibitor was tested in duplicate in 3 male and 3 female microsome samples.
Immunoblot (Western Blot)
The immunoblot determination was conducted using 100 µg of protein for CYP1A1, CYP1A2, and CYP2A6 and 30 µg for CYP3A4. The samples were preheated at 92°C for 5 min with 5 µL of sample buffer (Tris-HCl 7 mM, pH 6.8, SDS 1.5%, glycerol 20%, β-mercaptoethanol 5%, and bromophenol blue 0.02%) and run on a SDS-PAGE gel (T = 10%, C = 3.3%) (Laemmli, 1970) at 150 V constant voltage in a Trisglycine running buffer (Tris 25 mM, glycine 192 mM, pH 8.8) for 90 min. Proteins were then transferred to a PVDF membrane at a constant voltage of 100 V for 2.5 h in Dunn carbonate buffer (NaHCO 3 10 mM, Na 2 CO 3 3 mM, pH 9.9). After transfer, the membrane was washed 3 times with PBS-Tween 0.1%, 5 min each wash, and blocked with PBS-Tween 5% powdered milk for an hour at room temperature and constant shaking. After washing, the membrane was incubated with the primary antibody (rabbit anti-CYP450) prepared at a dilution of 1:1,000 in PBS-Tween 5% powdered milk for 1 h at room temperature with constant shaking. Finally, the PVDF membrane was washed 3 times with PBS-Tween 0.1%, 5 min each wash, and incubated in secondary antibody (goat anti-rabbit horseradish peroxidase) prepared in a 1:2,000 dilution in PBS-Tween 5% powdered milk for an hour at room temperature. Detection was carried out with the Opti-4CN goat antirabbit detection kit until colored bands were visible. The reaction was stopped by washing the membrane repeatedly with Milli-Q water (Millipore Corporation, Billerica, MA). Quantification of the bands was done using a BioRad Gel Doc XR system supplied with the BioRad Quantity One 1-D analysis software version 4.6.3.
Statistical Analysis
The enzyme kinetic constants K M and V max were determined by nonlinear regression using the Marquardt method adjusting the data to Michaelis-Menten enzyme kinetics using the following equation: v = V max [ 
S]/(K M + [S]), where v is the enzyme reaction velocity and [S]
represents substrate concentration (Marangoni, 2003; Bisswanger, 2008) . Nonlinear regression fitting was accomplished with the use of the following weighting function: ω = 1/y i α , where y i is the velocity for each substrate concentration and α is the magnitude of relation between residuals and variance (Kakkar et al., 1999; Marangoni, 2003) . Between sexes, biotransformation rates of prototype substrates were compared using a 2-sample t-test.
The CYP450-mediated production of AFB 1 epoxide in the presence of different concentrations of each inhibitor is expressed as mean percentage of inhibition of the corresponding control ± SD for each inhibitor concentration. Pearson correlation coefficients were calculated to determine the correlation between the activity of the CYP450 orthologs and their amount of protein. In all cases, normality, homoscedasticity, and independence of residuals were verified. Means within treatments were subjected to 1-way ANOVA. The probability level for significance was P < 0.05. When significant differences were found in the ANOVA analysis, means were separated using Dunnett's test. These calculations were performed using SAS software (SAS Institute, 2008) .
RESULTS
Prototype substrate enzymatic activity corresponding to the CYP450 enzymes CYP1A1, CYP1A2, CY-P2A6, and CYP3A4 was detected in both chicken and quail hepatic microsomes. The biotransformation of the prototype substrates followed typical Michaelis-Menten kinetics, confirming the presence of avian orthologs of CYP1A1, CYP1A2, CYP2A6, and CYP3A4 in chicken and quail liver. No CYP2D6 activity was found in any of the samples analyzed. No differences in male and female biotransformation constants were found for any type of bird and therefore data for enzyme kinetic constants for both sexes were pooled (Table 1) .
The addition of α-naphthoflavone and 8-methoxypsoralen (specific inhibitors of human CYP1A1/2 and CYP2A6, respectively) to the microsomal incubations caused a significant reduction in AFBO formation in both quail and chickens (Figure 1 ). The magnitude of the reduction in AFBO was significant at all concentrations tested (Figure 2 ). Furafylline and troleandomycin 1 Values are means of 6 observations per bird species (3 males and 3 females for each species). The K M and V max values were determined by nonlinear regression using the Marquardt method adjusting the data to MichaelisMenten enzyme kinetics using the following equation (CYP1A2 and CYP3A4 inhibitors, respectively) had no effect on AFBO production (data not shown). A strong linear relationship between AFB 1 epoxidation and coumarin 7-hydroxylation in quail and chicken microsomes was observed with Pearson correlation coefficients of 0.78 and 0.83, respectively (Figure 3) . No significant correlation was found between the other enzymatic activities tested and AFBO formation (data not shown).
Immunoblot of CYP450 avian orthologs showed proteins reacting with antibodies against human CYP2A6 and CYP3A4 in quail and chicken hepatic microsomes (Figure 4 ). In addition, CYP1A1 and CYP1A2 were not detected.
DISCUSSION
Although human CYP450 are not strictly orthologs of animal CYP450, some prototype substrates and inhibitors have been found to be useful tools in the identification of enzymatic activities in both domestic animals (Chauret et al., 1997) and fish (Renauld et al., 1999) . In the present study, the use of mammalian prototype substrates demonstrated the presence of enzymatic activities with typical Michaelis-Menten behavior, which strongly suggest the existence of avian orthologs of the human CYP1A1/2, CYP2A6, and CY-P3A4 enzymes. Previous studies had demonstrated the presence of the human orthologs of CYP2B1, CYP3E1, CYP1A1, CYP3A4 (Nebbia et al., 2003) , and CYP1A2 (Gorman et al., 1998) in chickens, and the results obtained in the present study confirmed the presence of CYP1A1/2 and CYP3A4 activity. However, no previous studies had reported CYP2A6 activity in chicken microsomes. In the present study, the existence of a chicken CYP2A6 ortholog was evidenced by the finding of enzymatic prototype activity for this enzyme (coumarin 7-hydroxylase) and the presence of immunoreactive proteins cross-reacting with antibodies against human CYP2A6 as shown in Figure 4 . In contrast to chicken CYP450 orthologs, no previous reports were found describing quail CYP450 orthologs.
The comparison of enzyme kinetic constants for AFB 1 epoxidation showed that quail liver microsomes have a higher AFBO production rate (higher V max value) and a higher affinity for AFB 1 (lower K M value) compared with chicken microsomes. These biochemical findings could explain the higher sensitivity of quail to aflatoxins compared with chickens that has been reported in in vivo trials (Leeson et al., 1995) . However, it is important to note that the differences in sensitivity to AFB 1 exhibited by poultry species is not only explained by bioactivation of AFB 1 (phase I metabolism) but also to conjugation of AFBO with glutathione (phase II metabolism), an important detoxification reaction of electrophilic metabolites reported in birds such as turkeys (Klein et al., 2000) and in some mammalian species (Esaki and Kumagai, 2002; Tulayakul et al., 2005) .
The results of the inhibition studies strongly suggest a key role for the quail and chicken CYP2A6 and CYP1A1 orthologs in the bioactivation of AFB 1 . Production of AFBO was inhibited significantly by α-naphthoflavone, which inhibits both CYP1A1 and CYP1A2 activities, whereas furafylline is a strong inhibitor of CYP1A2 (Sesardic et al., 1990; Kunze and Trager, 1993) . The fact that AFBO production was inhibited by α-naphthoflavone but not by furafylline suggests that it is the CYP1A1 ortholog that is responsible for AFBO formation rather than the CYP1A2 ortholog.
The analysis of the relationship between prototype substrate activities and AFB 1 epoxidation showed a strong relationship between CYP2A6 prototype activity and AFBO production in both quail and chickens. This finding further supports the notion that CYP2A6 plays a key role in the bioactivation of AFB 1 in these poultry species. The fact that CYP1A1 was not correlated with production of AFBO, even though the inhibition studies suggested a role for this enzyme, can be explained by the fact that 7-ethoxyresorufin can be metabolized by both CYP1A1 and CYP1A2 (Omiecinski et al., 1999) .
The immunoblot analysis of microsomal chicken and quail CYP450 confirmed the presence of CYP2A6 and CYP3A4 orthologs, providing further evidence for the existence of a chicken and quail CYP2A6 ortholog. However, no CYP1A1 or CYP1A2 could be detected. The reason for this lack of detection can be the low sensitivity of the method used (colorimetric) combined with the fact that these 2 enzymes are constitutively expressed in much lower amounts than CYP2A6 or CYP3A4. In previous studies, human CYP1A1 and CYP1A2 proteins have been detected by chemiluminiscence (Klein et al., 2000; Verbrugge et al., 2001; Yip and Coulombe, 2006 ) rather than colorimetry due to the higher sensitivity of the former method. Another possibility for the lack of detection of CYP1A1 and CYP1A2 is that the rabbit anti-human antibody does not cross-react with chicken and quail proteins due to differences in the antigenic determinants of the avian proteins.
No quail genes for CYP450 enzymes were found in the University of California (Santa Cruz) Genome Browser (http://genome.ucsc.edu). However, 3 of the human enzymes tested in the present study were found to have homologous genes in the chicken, as follows. The human CYP1A1 and CYP1A2 genes are homologous to the chicken CYP1A4 and CYP1A1 genes, respectively (71.7 and 70.2% homology, respectively). The human CYP3A4 is homologous to chicken CYP3A7 (69.2% homology). No chicken homologous of the human CY-P2A6 gene was found in the chicken genome database.
The results of the present study indicate that CY-P2A6 and, to a lesser extent, CYP1A1 are key phase I enzymes responsible for the bioactivation of AFB 1 into its toxic epoxide form in both quail and chickens. The role for CYP2A6 is supported by the strong inhibition of AFBO caused by specific CYP2A6 inhibitors and the strong relationship between CYP2A6 prototype substrate activity (coumarin 7-hydroxylation) and AFBO formation. Further, the presence of a quail and chicken ortholog of CYP2A6 was confirmed by immunoblot using antibodies against human CYP2A6. The higher turnover for AFBO formation and higher affinity for AFB 1 of the microsomal quail enzymes compared with chickens could explain the higher sensitivity of quail to AFB 1 . To further clarify the biotransformation of AFB 1 in quail and chickens, it is important to determine the phase II metabolism of phase I AFB 1 metabolites in these 2 species. Previous studies have shown that poor AFBO conjugation with glutathione could explain the high sensitivity to AFB 1 of turkeys (Klein et al., 2000) Figure 4. Immunoblot of the CYP2A6 and CYP3A4 quail and chicken cytochrome P450 (CYP450) orthologs. Lanes 1 to 6 correspond to the bands obtained with 6 different samples of microsomes. Lanes 7 to 9 correspond to microsomes containing cDNA-expressed human CYP450 enzymes as indicated in each graph. Standards are shown with their corresponding values. A total of 100 µg of protein for CYP2A6 and 30 µg for CYP3A4 were loaded and run on an isocratic SDS-PAGE gel (T = 10%, C = 3.3%). Samples were reduced with β-mercaptoethanol before analysis. Primary antibody (rabbit anti-CYP450) was prepared at a dilution of 1:1,000, whereas secondary antibody (goat anti-rabbit-horseradish peroxidase) was prepared in a 1:2,000 dilution. Detection was carried out with the Opti-4CN goat anti-rabbit detection kit (BioRad, Hercules, CA). and rats (Esaki and Kumagai, 2002; Tulayakul et al., 2005) . Future investigations should aim at identifying enzymes such as glutathione transferases that are responsible for the conjugation of AFB 1 metabolites in poultry species.
